Cabaletta Bio CABA
NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cabaletta Bio (CABA) Interest Expenses (2024 - 2026)

Cabaletta Bio (CABA) posted quarterly Interest Expenses of $7.2 million for Q4 2025, up 708.05% year-over-year from $894000.0 in Q4 2024, and down 67.39% quarter-over-quarter from $22.2 million in Q3 2025.

Analysis

Cabaletta Bio (CABA) Interest Expenses (2024 - 2026) Analysis & Trends

Cabaletta Bio's Interest Expenses history runs 8 years deep, the most recent figure standing at $7.2 million for Q4 2025.

  • In Q4 2025, Interest Expenses rose 708.05% year-over-year to $7.2 million; the TTM figure through Dec 2025 stood at $9.3 million (up 344.82% YoY), while the FY2025 annual figure was $157.8 million, up 42.56% from the prior year.
  • Interest Expenses for Q4 2025 stood at $7.2 million, down from $22.2 million in the prior quarter.
  • The five-year high for Interest Expenses was $69.8 million in Q1 2024, with the low at -$1.7 million in Q4 2023.
  • The 5-year median for Interest Expenses is $10.1 million (2022), against an average of $16.2 million.
  • The sharpest annual moves came in 2022 and 2023: Interest Expenses surged 122840.43% in 2022, then tumbled 158.73% in 2023.
  • Cabaletta Bio's Interest Expenses stood at $2367.0 in 2021, then soared by 122840.43% to $2.9 million in 2022, then tumbled by 158.73% to -$1.7 million in 2023, then soared by 152.31% to $894000.0 in 2024, then soared by 708.05% to $7.2 million in 2025.
  • Business Quant data shows CABA's Interest Expenses at $7.2 million in Q4 2025, $22.2 million in Q3 2025, and $4.6 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Cabaletta Bio 522.26 Mn 522.26 Mn - 517,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 517,000.00
Dec 31, 2025 555,000.00
Sep 30, 2025 584,000.00
Jun 30, 2025 571,000.00
Mar 31, 2025 294,000.00
Dec 31, 2024 748,000.00